Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 276, Issue 13, Pages 10224-10228Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.C000905200
Keywords
-
Categories
Funding
- NCI NIH HHS [CA-39807, CA82621] Funding Source: Medline
Ask authors/readers for more resources
The reduced folate carrier (RFC1) is an important route by which the major blood folate, B-methyltetrahydrofolate, is transported into mammalian cells. In this study we determined the consequences of inactivation of RFC1 in mice by homologous recombination. While RFC1-null embryos died in utero before embryonic day 9.5 (E9.5), near-normal development could be sustained in RFC1(-/-) embryos examined at E18.5 by supplementation of pregnant RFC1(+/-) darns with l-mg daily subcutaneous doses of folic acid. About 10% of these animals went on to live birth but died within 12 days. These RFC1(-/-) mice showed a marked absence of erythropoiesis in bone marrow, spleen, and liver along with lymphoid depletion in the splenic white pulp and thymus, In addition, there was some impairment of renal and seminiferous tubule development. These data indicate that in the absence of RFC1 function, neonatal animals die due to failure of hematopoietic organs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available